查詢結果分析
相關文獻
- Treatment of Severe Male Infertility and Low Fertilization in Conventional in Vitro Fertilization Using Intracytoplasmic Sperm Injection of Human Oocytes
- 男性不孕症
- Outcome of Intracytoplasmic Sperm Injection in the Treatment of Male-Factor Infertility: Experience at Shin Knog WHS Memorial Hospital
- Comparable Clinical Outcomes of Tubal Embryo Transfer for Oligoastheno-Teratozoospermia Treated with Intracytoplasmic Sperm Injection and for Female Infertility Treated with in Vitro Fertilization
- Zona-Free Oocyte Fertilized with Intracytoplasmic Sperm Injection and Underwent Further Division: Case Report and Literature Review
- 卵子細胞質內精子注射治療之遺傳諮詢
- Relationship of Follicle Number and Sperm Parameter to Pregnancy Rate in Different Ovulation Induction Protocol Induced Intrauterine Insemination Cycles
- 單一副睪丸精子顯微注射術:對於阻塞性無精症所引起的男性不孕症的革命性人工生殖技術療法
- 中藥方劑對男性不孕症之評估(3)
- 因輸精管阻斷造成的無精蟲症手術矯正的必要性
頁籤選單縮合
題 名 | Treatment of Severe Male Infertility and Low Fertilization in Conventional in Vitro Fertilization Using Intracytoplasmic Sperm Injection of Human Oocytes=精蟲顯微注射(ICSI)對重度男性不孕症及體外精卵低受精率病人之治療 |
---|---|
作 者 | 楊政達; 蘇聰賢; 陳忠義; 黃俊嘉; 李茂盛; | 書刊名 | 中華民國婦產科醫學會會刊雜誌 |
卷 期 | 36:1 1997.03[民86.03] |
頁 次 | 頁7-12 |
分類號 | 415.8616 |
關鍵詞 | 精蟲顯微注射; 男性不孕症; Intracytoplasmic sperm injection; Male infertility; Fertilization failure; |
語 文 | 英文(English) |
英文摘要 | 本文回溯研究自83年7月至85年5月使用ICSI治療之病人,其必須符合下列2種標 準之一: (1) 重度男性不孕症: 精蟲數每 cc 小於一千萬或活動力小於 20 % (2) 前次 IVF 治療之精卵受精率低於 30 %。共有 486 治療週期計 4,040 個卵接受精蟲顯微注射。 我們將這段期間分成 3 個階段:第一階段 83 年 7 月至 84 年 5 月, 第二階段 84 年 6 月至 84 年 9 月,第三階段 84 年 10 月至 85 年 5 月。其受精率分別是 32.6 %,56.7 %及 70.4 %,卵的損壞率則是 28.5 %,19.8 %,及 10.6 %。 第二階段受精率顯著提 高, 而卵破壤率顯著下降。 若以重度男性不孕症與前次 IVF 受孕失敗兩群病人而言, 則 ICSI 對後者之治療有較高之受精率 (69.8 % VS 52.9 % )。 精蟲顯微注射對重度男性不 孕症及傳統 IVF 精卵體外低受精率之患者提供了新的希望。 to May 1996. We divided this period into three stages: stage I from June 1994 to May 1995, stage II from June 1995 to September 1995, and stage III from October 1995 to May 1996. The fertilization rate for ICSI was significantly better during stage III (70.4%) than stage II (56.1%) or I (32.6%). The oocyte damage rate for stage III (10.6%) was lower than stage II (19.8%) or I (28.5%). We believe that the improvement in the fertilization and pregnancy rates since stage II was due to technical improvements.Conclusion: Accumulation of technical experience is crucial for the outcome of the procedure.ICSI has revolutionized the treatment of severe male infertility and low fertilization in conventional IVF, and will become an alternative method when assisted fertilization is required. |
本系統中英文摘要資訊取自各篇刊載內容。